LimFlow SA

LimFlow SA When all Chronic Limb-Threatening Ischemia (CLTI) treatment options have been exhausted, LimFlow is Enter LimFlow and the investigational LimFlow System.

When peripheral artery disease (PAD) progresses to Chronic Limb-Threatening Ischemia (CLTI), a patient’s options become limited. As the disease evolves to its late stages, patients may no longer be candidates for balloons or stents and may face bypass surgery, or worse, amputation. However, they are ready to do anything to resolve the pain and regain quality of life. In a minimally-invasive fashio

n, the LimFlow System is designed to bypass blocked arteries in the leg and rush blood back into the foot, potentially avoiding major amputation, resolving pain and promoting wound healing. The PROMISE II trial is now enrolling nationwide: https://limflow.com/us/us-promise-ii-clinical-trial/

CAUTION: Investigational device. Limited by Federal law to investigational use.

Address

3031 Tisch Way 110 Plaza West
Santa Clara, CA
95128

Website

Alerts

Be the first to know and let us send you an email when LimFlow SA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to LimFlow SA:

Shortcuts

Share

Category